Skip to main content
. 2024 Aug 12;15:1360587. doi: 10.3389/fphar.2024.1360587

FIGURE 1.

FIGURE 1

Shikonin treatment can inhibit colon cancer cell growth in a dose-dependent way. (A) Chemical structural formula of shikonin. (B–D) CCK-8 assay detecting the cell viabilities and IC50 values of HT29 and HCT116 cell lines. (E,F) Images of shikonin treatment dose-dependently inhibiting the growth of HT29 and HCT116 cells. Data are shown as mean ± S.E.M. **p < 0.001; ****p < 0.0001. Each experiment was performed in triplicate and repeated three times.